Aarti Drugs Earnings Estimate

By analyzing Aarti Drugs' earnings estimates, investors can diagnose different trends across Aarti Drugs' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Aarti Drugs Limited is based on EPS before non-recurring items and includes expenses related to employee stock options. Aarti Drugs is projected to generate 4.275 in earnings per share on the 31st of March 2025. Aarti Drugs earnings estimates module stress-tests analyst consensus about projected Aarti Drugs Limited EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Aarti Drugs, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Aarti Drugs' earnings estimates, investors can diagnose different trends across Aarti Drugs' analyst sentiment over time as well as compare current estimates against different timeframes. As of 11/27/2024, Gross Profit is likely to grow to about 8.5 BCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.